Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Primary Results From TROPION-Breast01

32 biomedical and clinical sciences (for-2020), 3202 clinical sciences (for-2020), 3211 oncology and carcinogenesis (for-2020), clinical research (rcdc), breast cancer (rcdc), patient safety (rcdc), clinical trials and supportive activities (rcdc), cancer (rcdc)